How Do PCSK9 Inhibitors Influence Cholesterol Levels?
PCSK9 inhibitors significantly reduce LDL cholesterol levels, which are often referred to as "bad cholesterol." By preventing PCSK9 from degrading LDL receptors, these drugs enable more receptors to be available to clear LDL cholesterol from the bloodstream. Clinical trials have shown that PCSK9 inhibitors can reduce LDL cholesterol levels by up to 60%, making them highly effective in managing hypercholesterolemia.
